Skip to main content

Oral and Parenteral Drug Therapy for Cancer Pain

  • Chapter
  • 51 Accesses

Part of the book series: Current Management of Pain ((CUMP,volume 3))

Abstract

Pain in the cancer patient is often a consequence of tumor infiltration or compression of bone, soft tissue, peripheral nerve or spinal cord, or vascular occlusion [4,17]. The most effective management of cancer pain involves treatment of the tumor with surgery, radiation therapy, or chemotherapy, if possible. However, it is often necessary to manage pain with analgesic drugs prior to the introduction of specific antitumor therapy. Moreover, a significant percentage of patients will have chronic pain as a sequela of cancer treatment [42] (see table 1–1, Chapter 1, this volume). Finally, although invasive neurosurgical and anesthetic approaches to cancer pain management are indicated in a minority of patients, with a few exceptions (e.g., celiac ganglion blocks for pancreatic pain) they are not first-line treatments [16]. Therefore, the use of analgesic drugs has become the mainstay of acute and chronic cancer pain management, and narcotic analgesics are the drugs of choice for management of severe pain [4,15,55].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amer S, Amer B (1985): Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol Scand 29: 32–36.

    Google Scholar 

  2. Beaver WT, Feise G (1976): Comparison of the analgesic effects of morphine, hydroxyzine and their combination in patients with post-operative pain. In: Bonica JJ, Albe-Fessard D (eds), Advances in Pain Research and Therapy. New York: Raven Press, pp 553–557.

    Google Scholar 

  3. Beaver WT, Wallenstein SL, Houde RW, et al. (1966): A comparison of the analgesic effect of methotrimeprazinc and morphine in patients with cancer. Clin Pharmacol Ther 7: 436–446.

    PubMed  CAS  Google Scholar 

  4. Bonica, JJ (1985): The treatment of cancer pain: current status and future needs. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 589–616.

    Google Scholar 

  5. Botney M, Fields HL (1983): Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 13: 160–164.

    Article  PubMed  CAS  Google Scholar 

  6. Brogden RN, Speigt TM, Avery GS (1973): Pentazocine: a review of pharmacological properties, therapeutics, efficacy and dependence. Drugs 5: 6–91.

    Article  PubMed  CAS  Google Scholar 

  7. Bromage PR (1985): Clinical aspects of intrathecal and epidural opiates. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 733–748.

    Google Scholar 

  8. Campbell CF, Matson JB, Weiler JM (1983): Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Ann Int Med 98: 51–52.

    PubMed  CAS  Google Scholar 

  9. Chauvin M, Samii K, Schermann JM, et al. (1982): Plasma pharmacokinetics of morphine after i.m., extradural and intrathecal administration. Br J Anaesth 54: 843–848.

    Article  PubMed  CAS  Google Scholar 

  10. Cleeland CS, Cleeland LM, Dar R, et al. (1986): Factors in influencing physician management of cancer pain. Cancer 58: 796–800.

    Article  PubMed  CAS  Google Scholar 

  11. Cousins MJ, Mather LE (1984): Intrathecal and epidural administration of opioids. Anesthesiology 61: 276–310.

    Article  PubMed  CAS  Google Scholar 

  12. Coyle N, Mauskop A, Maggard J, et al. (1986): Continuous subcutaneous infusion of opiates in cancer patients with pain. One Nurs Forum 13: 53–57.

    CAS  Google Scholar 

  13. Feinmann C (1985): Pain relief by antidepressants: possible modes of action. Pain 23: 1–8.

    Article  PubMed  CAS  Google Scholar 

  14. Foley, KM (1981): Current issues in the management of cancer pain: Memorial Sloan-Kettering Cancer Center. In: Loreng NG (ed), New Approaches to Treatment of Chronic Pain. Nida Research Monograph 36: 169–181.

    Google Scholar 

  15. Foley KM (1982): The practical use of narcotic analgesics. Med Clin North Am 66: 1091–1104.

    PubMed  CAS  Google Scholar 

  16. Foley, KM, Sundaresan N (1984): Management of cancer pain. In: Devita VT, Hellman S, Rosenberg SA (eds), Cancer: Principles and Practice of Oncology. Philadelphia: J.B. Lippincott Co., pp 1941–1961.

    Google Scholar 

  17. Foley KM (1985): The treatment of cancer pain. N Engl J Med 313: 84–95.

    Article  PubMed  CAS  Google Scholar 

  18. Foley KM (1985): Adjuvant analgesic drugs in cancer pain management. In: Aronoff GM (ed), Evaluation and Treatment of Chronic Pain. Baltimore-Munich: Urban and Schwarzenberg.

    Google Scholar 

  19. Forrest WH, Brown BW, Brown CR, et al. (1977): Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 296: 712–715.

    Article  PubMed  Google Scholar 

  20. Fraser DG (1980): Intravenous morphine infusion for chronic pain. Ann lot Med 93: 781–782.

    CAS  Google Scholar 

  21. Graves D, Foster TS. Batenhorst RL, et al. (1983): Patient-controlled analgesia. Ann Int Med 99:360–366.

    Google Scholar 

  22. Greenberg HS, Taren J, Ensminger WD, Doan K (1982): Benefit from and tolerance to containuous intrathecal infusion of morphine for intractable cancer pain. J Neurosurg 57: 360–364.

    Article  PubMed  CAS  Google Scholar 

  23. Harris LS (1979): Cannabinoids as analgesics. In: Beers RF, Bassett EG (eds), New York: Raven Press. Mechanism of Pain and Analgesic Compounds.

    Google Scholar 

  24. Houde RW (1974): The use and misuse of narcotics in the treatment of chronic pain. Adv Neurol 4: 527–536.

    Google Scholar 

  25. Inturrisi CE, Max MB, Foley KM, et al. (1984): The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med 210: 1213–1217.

    Article  Google Scholar 

  26. Kaiko RF, Wallenstein SL, Rogers AG, et al. (1981): Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. N Engl J Med 304: 1501–1505.

    Article  PubMed  CAS  Google Scholar 

  27. Kaiko RF, Wallenstein SL, Rogers AG, et al. (1982): Narcotics in the elderly. Med Clin North Am 66: 1079–1089.

    PubMed  CAS  Google Scholar 

  28. Kaiko RF, Foley KM, Grabinski PY, et al. (1983): Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 13: 180–185.

    Article  PubMed  CAS  Google Scholar 

  29. Kanner RM, Foley KM (1981): Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 362: 161–172.

    Article  PubMed  CAS  Google Scholar 

  30. Kantor TG (1982): The control of pain by nonsteroidal anti-inflammatory drugs. Med Clin North Am 66: 1053–1059.

    PubMed  CAS  Google Scholar 

  31. King JS, Gallant P, Myerson V, et al. (1976): The effects of anti-inflammatory agents on the responses and the sensitization of unmyelinated (C) fiber polymodal receptors. In: Zotterman Y (ed), Sensory Function of the Skin of Primates. Oxford: Pergamon Press, pp 441–461.

    Google Scholar 

  32. Leavens ME, Hill CS, Cech DA, et al. (1982): Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J Neurosurg 56: 241–242.

    Article  PubMed  CAS  Google Scholar 

  33. Lenzi A, Galli G, Gandolfini M, et al. (1985): Intraventricular morphine in paraneoplastic painful syndrome of the cervicofacial region: experience in thirty-eight cases. Neurosurgery 17: 6–11.

    Article  PubMed  CAS  Google Scholar 

  34. Levin D, Cleeland CS, Dar R (1985): Public attitudes toward cancer pain. Cancer 56: 2337–2339.

    Article  PubMed  CAS  Google Scholar 

  35. Lobato RD, Madrid JL, Fatela LV, et al. (1985): Analgesia elicited by low-dose intraventricular morphine in terminal cancer patients. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 673–681.

    Google Scholar 

  36. Max MB, Inturrisi CE, Kaiko RF, et al. (1985): Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain. Clin Pharmacol Ther 38: 631–641.

    Article  PubMed  CAS  Google Scholar 

  37. Miser AW, Davis DM, Hughes CS, et al. (1983): Continuous subcutaneous infusions of morphine in children with cancer. Am J Dis Child 137: 383–385.

    PubMed  CAS  Google Scholar 

  38. Miser AW, Miser JS, Clark BS (1980): Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr 5: 930–932.

    Google Scholar 

  39. Nahata MC, Miser AW, Miser JS, et al. (1984): Analgesic plasma concentrations of morphine in children with terminal malignancy receiving a continuous subcutaneous infusion of morphine sulfate to control severe pain. Pain 18: 109–114.

    Article  PubMed  CAS  Google Scholar 

  40. Neis A, Robinson DS, Friedman MJ, et al. (1977): Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiat 134: 790–793.

    Google Scholar 

  41. Newman RG (1983): The need to redefine “addiction”. N Engl J Med 308: 1096–1098.

    Article  PubMed  CAS  Google Scholar 

  42. Payne R, Foley KM (1984): Advances in the management of cancer pain. Cancer Treat Rep 68: 173–83.

    PubMed  CAS  Google Scholar 

  43. Payne R (1986): The role of spinal opiates and opioid peptides in the management of cancer pain. Med Clin North Am (in press).

    Google Scholar 

  44. Perry S, Heidrich G (1982): Management of pain during debridement: a survey of U.S. burn units. Pain 13: 267–280.

    Article  PubMed  CAS  Google Scholar 

  45. Porter J, Jick H (1980): Addiction rare in patients treated with narcotics. N Engl J Med 302: 133.

    Google Scholar 

  46. Portenoy RK, Moulin DE, Rogers A, et al. (1986): I.V. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep 70: 575–581.

    PubMed  CAS  Google Scholar 

  47. Roquefeuil B, Benezech J, Blanchet P, et al. (1984): Intraventricular administration of morphine in patients with neoplastic intractable pain. Surg Neurol 21: 155–158.

    Article  PubMed  CAS  Google Scholar 

  48. Rotstein J, Good RA (1957): Steroid pseudorheumatism. Arch Int Med 99: 545–555.

    CAS  Google Scholar 

  49. Schlechter NE (1985): Pain and pain control in children. Curr Prob Pediatr 15: 1–67.

    Google Scholar 

  50. Spiegel K, Kalb R, Pasternak GW (1983): Analgesic activity of tricyclic antidepressants. Ann Neurol 13: 462–465.

    Article  PubMed  CAS  Google Scholar 

  51. Swerdlow M (1984): Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 7: 51–82.

    Article  PubMed  CAS  Google Scholar 

  52. Tameson A, Hartvig P, Fagerlund C, et al. (1982): Patient-controlled analgesia: clinical experience. Acta Anesthesiol Scand (Suppl) 14: 157–160.

    Article  Google Scholar 

  53. Twycross RG (1977): Value of cocaine in opiate-containing elixirs. Br Med J 2: 1348.

    Article  PubMed  CAS  Google Scholar 

  54. Twycross RG (1977): Choice of strong analgesic in terminal cancer: diamorphine or morphine? Pain 3: 93–104.

    Article  PubMed  CAS  Google Scholar 

  55. Twycross RG, Lack SA (1983): Symptom Control in Far Advanced Cancer: Pain Relief. London: Pitman Publishing.

    Google Scholar 

  56. Ventafridda V, Spoldi E, Caraceni A, et al. (1986): The importance of continuous subcutaneous morphine administration for cancer pain. The Pain Clinic 1: 47–55.

    Google Scholar 

  57. Waldmann CS, Eason JR, Rambohul E, et al. (1984): Serum morphine levels. A comparison between continuous subcutaneous infusion and continuous intravenous infusion in postoperative patients. Anaesthesia 39: 768–771.

    Article  PubMed  CAS  Google Scholar 

  58. Watson CP, Evans RJ, Reid K, et al. (1982): Amitriptyline vs. placebo in postherpetic neuralgia. Neurology 32: 671–73.

    PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Payne, R. (1989). Oral and Parenteral Drug Therapy for Cancer Pain. In: Cancer Pain. Current Management of Pain, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0875-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0875-1_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8223-5

  • Online ISBN: 978-1-4613-0875-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics